At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
Intranasal Neurostimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Controlled, Crossover Study Comparing Tear Production by Nasal Neurostimulation Versus Active Control
In Brief
A clinical study evaluating Intranasal Neurostimulator for Dry Eye and 2 related conditions. Completed, enrolled 27 participants.
Detailed Summary
This crossover design study evaluates the effectiveness of the Oculeve Intranasal Neurostimulator comparing the effect of intranasal (active) versus extranasal (control) stimulation on tear production as measured by the Jones Schirmer test in participants with dry eye disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye, Dry Eye Syndromes, Keratoconjunctivitis Sicca
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartAug 2016
Primary CompletionOct 2016
First PostedNov 2016
TodayJul 2026
First PostedNov 22, 2016
Enrollment StartAug 31, 2016
Primary CompletionOct 31, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.6 years ago
Interventions
Intranasal Neurostimulatordevice
The device delivers small electrical currents, activating nerves that stimulate the body's natural tear production system.